Viking Therapeutics Inc.

NASDAQ: VKTX · Real-Time Price · USD
40.04
-0.20 (-0.50%)
At close: Aug 15, 2025, 3:59 PM
40.74
1.75%
After-hours: Aug 15, 2025, 07:57 PM EDT

Viking Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-65.56M -45.63M -35.42M -24.94M -22.25M -27.36M -24.61M -22.53M -19.23M -19.53M -19.56M -15.77M -17.43M -16.1M -12.36M -13.24M -15.38M -14.01M
Depreciation & Amortization
-5.59M 111K 110K 87K 75K 74K 74K 73K 73K 72K 72K 142K n/a 77K 76K 75K 73K 72K
Stock-Based Compensation
13.55M 11.35M 5.67M 8.98M 7.08M 7.98M 4.08M 4.48M 4.62M 3.57M 2.16M 1.94M 2.22M 2.36M 1.43M 1.6M 1.49M 1.58M
Other Working Capital
n/a -12.95M -6.46M 8.46M -13.88M 18.24M 3.68M 1.35M 3.21M 4.73M 1.09M 2.96M -1.7M 746K -880K 1.08M -45K -539K
Other Non-Cash Items
10.54M -18.16M -4M -5.06M -4.04M 37K 36K 12K 43K -349K -75K 195K 12K 686K 12K -33K 24K 26K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -2.7M -3.15M -1.97M n/a n/a n/a n/a n/a 755K 972K 1.04M 1.14M
Change in Working Capital
n/a n/a 2.46M -1.03M -8.01M 15.95M 5.48M 1.46M 5.02M -8.4M 6.48M -3K 1.26M 2.45M -2.27M -296K -682K 321K
Operating Cash Flow
-47.06M -52.33M -31.18M -21.96M -28.51M -6.13M -17.64M -19.66M -11.44M -24.64M -10.93M -13.5M -13.44M -10.53M -12.35M -10.93M -13.43M -10.88M
Capital Expenditures
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-123.48M -232.61M -136.96M -149.99M -229.82M -596.6M -97.53M -79.4M -243.98M -57.4M -44.61M -10.45M -35.7M -30.68M -35.57M -24.17M -59.6M -48.68M
Sales Maturities Of Investments
-11K 2.47M 143.54M 175.89M 103.76M 136.81M 133.27M 66.86M 39.49M 59.59M 51.87M 37.34M 54.68M 32.3M 62.98M 37.78M 63.16M 42.05M
Other Investing Acitivies
165.99M 293.39M n/a n/a -126.06M 136.15M 35.73K -12.53K -204.48K 2.2K 7.26K 26.89K 18.98M 1.62M 27.41M 13.62M 3.56M -6.63M
Investing Cash Flow
42.51M 63.24M 6.58M 25.9M -126.06M -459.79M 35.73M -12.53M -204.48M 2.2M 7.26M 26.89M 18.98M 1.62M 27.41M 13.62M 3.56M -6.63M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a 42.1K n/a n/a n/a n/a 37K -37K -1.03K n/a -1.67M -5.12M n/a n/a n/a -473K
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
507K 349K 47.66M -44.14M 2.9M 8.92M 188K -1.97M -2.79M 5.9M 10.75M n/a 84K 115K 47K -234K 1.9M 5.19M
Financial Cash Flow
507K 349K 1M 2.52M 2.9M 606.04M 188K -74K 267.08M 4.18M 10.75M 10K -1.59M -5.01M 47K -256K 1.9M 5.19M
Net Cash Flow
-4.06M 11.26M -23.67M 6.43M -151.66M 140.06M 18.33M -32.33M 51.16M -18.27M 7.22M 13.18M 3.77M -13.92M 15.11M 2.44M -7.98M -12.31M
Free Cash Flow
-47.06M -52.33M -31.18M -21.96M -28.51M -6.13M -17.64M -19.66M -11.44M -24.64M -10.93M -13.5M -13.44M -10.53M -12.35M -10.93M -13.43M -10.88M